Pfizer: A Strong Product Pipeline Could Lead To Significant Upside

My last article on Pfizer (NYSE: PFE )(NEOE: PFE:CA ) was bullish and published back in February, 2024. I am even more bullish now because the stock seems to have found a bottom. I am also bullish because it appears thatLong-time stock market investor focused on strategic buying opportunities with dividend and value stocks. This investment strategy has resulted in a near 5 star rating on Tipranks.com and over 9,000 followers on Seeking Alpha. Follow me on Twitter for my latest trading ideas: @Hawkinvest1Ana ...